New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 3, 2014
07:10 EDTGSK, ISISIsis Pharmaceuticals earns $1M from GlaxoSmithKline for advancing ISIS-TTR Rx
Isis Pharmaceuticals (ISIS) announced that it has earned a $1M milestone payment from GlaxoSmithKline (GSK) related to the initiation of an open-label extension study of ISIS-TTR, which is being offered to those patients with familial amyloid polyneuropathy who have completed dosing in the Phase 2/3 study of ISIS-TTR. ISIS-TTR is an antisense drug in development with GSK for the treatment of transthyretin amyloidosis. Including this milestone payment, Isis has earned $25M in upfront and milestone payments for advancing ISIS-TTRRx. This $1M milestone payment is the third of the $50M in milestone payments Isis is eligible to earn as the Phase 2/3 study progresses.
News For ISIS;GSK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 16, 2015
09:14 EDTGSKAdamis says albuterol HFA product study met clinical FEV1 primary endpoint
Subscribe for More Information
08:15 EDTGSKGlaxoSmithKline and Theravance announce launch of Anoro in Spain
In a regulatory filing, GlaxoSmithKline (GSK) and Theravance (THRX) announced the launch of Anoro in Spain following the approval in Europe in May 2014. Anoro Ellipta is indicated as a once-daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease. Anoro Ellipta is a combination of two bronchodilators, umeclidinium, a long-acting muscarinic antagonist and vilanterol, a long-acting beta2 agonist, in a single dry powder inhaler, the Ellipta. The approved dose of UMEC/VI is 55/22mcg. UMEC/VI has been developed under the 2002 LABA collaboration agreement between Glaxo Group Limited and Theravance.
April 15, 2015
11:53 EDTGSKGlaxoSmithKline initiated with a Sell at Societe Generale
April 10, 2015
19:43 EDTISISIsis Pharmaceuticals management to meet with JPMorgan
Subscribe for More Information
April 8, 2015
16:11 EDTISISRegulus files to sell 3.3M shares for Isis Pharmaceuticals
Subscribe for More Information
April 7, 2015
07:14 EDTGSKEyeforpharma to hold a summit
Philadelphia 2015 Commercial Pharma Summit is being held in Philadelphia on April 7-8.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use